"MDMA Will be a Prescribable Medicine in Two Years" | Interview with PETER GASSER, MD | ICPR 2022

"MDMA Will be a Prescribable Medicine in Two Years" | Interview with PETER GASSER, MD | ICPR 2022

PETER GASSER, MD is a Psychiatrist and Psychotherapist in Switzerland.
Recorded at the Interdisciplinary Conference on Psychedelic Research (ICPR) 2022, in Haarlem, The Netherlands.
https://www.icpr-conference.com/
https://drugreporter.net
Questions:
0:00 Intro
0:05 Please introduce yourself and your work!
0:54 What brought you into this field?
1:52 Why are therapists interested in psychedelics?
3:15 How do psychedelics compare to traditional psychiatric drugs?
4:25 Is it the substance that has the healing potential, or is it only the substance embedded in this therapeutic context, assisting psychotherapy?
5:53 What does psychedelic assisted therapy look like in the real world?
7:05 Do you have any exclusion criteria? People you definitely would not work with?
8:18 Can a psychedelic experience induce a psychotic episode in an otherwise healthy individual?
9:24 What kind of training professionals need to provide psychedelic therapy?
10:34 Do you think therapists need subjective experiences with psychedelic drugs?
11:33 This is a multi hour long session, and must be very exhausting for the therapist. What does it look like from your side?
13:11 Psychedelic therapy now is mostly available for the upper middle class. Do you think the costs can be reduced and made available for the wider public and more marginalised people?
14:24 You did the first human LSD study after the long ban. How do you feel about the current wave of new research?
15:34 How do you see the future of psychedelics will find their way to mainstream medical care?


Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(116)

MARC B. AIXALÀ: Bad trips can transform into potentially positive outcomes

MARC B. AIXALÀ: Bad trips can transform into potentially positive outcomes

At ICPR 2024, we talked to psychologist and psychotherapist Marc B. Aixalà about how so-called “bad trips” can be reframed as difficult but potentially transformative experiences, and the importance o...

26 Touko 16min

PAREA is Translating Psychedelic Science Evidence to Policy at the EU Level – An Interview with Tadeusz Hawrot

PAREA is Translating Psychedelic Science Evidence to Policy at the EU Level – An Interview with Tadeusz Hawrot

Tadeusz Hawrot is the founder of the Psychedelic Access and Research European Alliance (PAREA), a Brussels-based initiative working to prepare Europe for the integration of psychedelic-assisted therap...

20 Huhti 30min

Strong Military Budget for Europe, but Not at the Cost of Community Health and Safety | An Interview with Ganna Dovbakh

Strong Military Budget for Europe, but Not at the Cost of Community Health and Safety | An Interview with Ganna Dovbakh

With the new EU drug strategy now adopted, key questions remain about its direction and implementation—especially the balance between public health, human rights, and security. We spoke with Anna Dovb...

17 Huhti 26min

Dismantling Orbán’s System - Drugreporter interviewed by Arild Knutsen

Dismantling Orbán’s System - Drugreporter interviewed by Arild Knutsen

As Hungary heads toward a pivotal election, the camera turns on two of its most prominent drug policy advocates. In this interview conducted by Arild Knutsen, Drugreporter founders Péter Sárosi and Is...

10 Huhti 57min

Every step to improve lives is worth fighting for — Martin Jelsma on a 30-year drug policy struggle

Every step to improve lives is worth fighting for — Martin Jelsma on a 30-year drug policy struggle

The global drug control system is under growing pressure, as countries experiment with regulation and long-standing assumptions are being challenged. Martin Jelsma, who is stepping down from the Trans...

31 Maalis 37min

UNGASS Promises Unfulfilled: Marie Nougier on the Challenges Facing Global Drug Policy

UNGASS Promises Unfulfilled: Marie Nougier on the Challenges Facing Global Drug Policy

Ten years after the 2016 UN General Assembly Special Session on drugs (UNGASS), a new report by the International Drug Policy Consortium takes stock of progress and remaining gaps in global drug polic...

27 Maalis 16min

“I’m incredibly proud of what we built” — Ann Fordham on Leaving IDPC After 17 Years

“I’m incredibly proud of what we built” — Ann Fordham on Leaving IDPC After 17 Years

After 15 years at the helm of the International Drug Policy Consortium, Ann Fordham is stepping down as Executive Director. Under her leadership, IDPC has grown into one of the most influential global...

25 Maalis 20min

Sabba: Building the Future of Psychedelic Therapy Education” — Interview with Jeremy Rudy

Sabba: Building the Future of Psychedelic Therapy Education” — Interview with Jeremy Rudy

Jeremy Rudy, founder of the Sabba Collective, explains how psychedelic therapy can be integrated into society safely and responsibly — from education to policy.Jeremy Rudy is the founder and CEO of th...

23 Maalis 20min

Suosittua kategoriassa Politiikka ja uutiset

aikalisa
uutiscast
ootsa-kuullut-tasta-2
rss-ootsa-kuullut-tasta
rss-podme-livebox
rss-seksicast
rss-vaalirankkurit-podcast
otetaan-yhdet
politiikan-puskaradio
aihe
rikosmyytit
rss-kovin-paikka
rss-kaikki-uusiksi
tervo-halme
rss-asiastudio
rss-girls-finish-f1rst
rss-varsinaista-puhetta